https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-02-24 / Oncol Lett 2016 Apr;11(4):2605-2610
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-02-24 / Oncol Lett 2016 Apr;11(4):2605-26102016-02-24 00:00:002019-02-15 08:45:42Dendritic cell vaccine and cytokine-induced killer cell therapy for the treatment of advanced non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-02-10 / Cancer Immunol. Immunother. 2016 Mar;65(3):327-39
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-02-10 / Cancer Immunol. Immunother. 2016 Mar;65(3):327-392016-02-10 00:00:002019-02-15 08:49:42Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-02-09 / Ther Adv Urol 2016 Jun;8(3):203-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-02-09 / Ther Adv Urol 2016 Jun;8(3):203-142016-02-09 00:00:002016-02-09 00:00:00Novel immunotherapeutic approaches to the treatment of urothelial carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2016-02-01 13:56:132020-05-27 11:44:02IOZK Beitrag in der Fachzeitschrift für Orthomolekulare Medizin, Sonderheft: Onkologie
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-02-01 / Melanoma Res. 2016 Feb;26(1):1-11
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-02-01 / Melanoma Res. 2016 Feb;26(1):1-112016-02-01 00:00:002019-02-15 08:49:37Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma
